126
Participants
Start Date
July 31, 2024
Primary Completion Date
January 31, 2026
Study Completion Date
December 31, 2026
Hydroxychloroquine Oral Tablet
Hydroxychloroquine is taken at the dose of 0.1g / dose, twice a day for 1 year, regardless of food intake.
Eltrombopag
Participants will take eltrombopag for at least 24 weeks, the dose of eltrombopag is adjusted according to participants' platelet count.
RECRUITING
Shanghai Zhongshan Hospital, Shanghai
RECRUITING
Wusong Hospital, Zhongshan Hospital, Fudan University, Shanghai
RECRUITING
Shanghai Jinshan Hospital, Shanghai
RECRUITING
Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai
RECRUITING
Health and Humanity Research Centre, Hongkong, China., Hong Kong
RECRUITING
Dr. Stanley Ho Medical Foundation, Macao
RECRUITING
University Hospital, Macau University of Science and Technology., Macao
Shanghai Zhongshan Hospital
OTHER
Shanghai Jinshan Hospital
OTHER
Zhongshan Qingpu Hospital, Fudan University
UNKNOWN
Zhongshan Wusong Hospital, Fudan University
UNKNOWN
Macau University of Science and Technology Hospital
OTHER
Health and Humanity Research Centre, Hongkong
UNKNOWN
Dr. Stanley Ho Medical Foundation, Macau
UNKNOWN
Yunfeng Cheng
OTHER